Review
Published on 25 Nov 2020
Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2020.569843
- 9,300 views
- 19 citations



